Charles Schwab’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.92M | Buy |
299,377
+25,734
| +9% | +$594K | ﹤0.01% | 2185 |
|
|
2025
Q1 | $7.39M | Buy |
273,643
+508
| +0.2% | +$13.7K | ﹤0.01% | 2102 |
|
|
2024
Q4 | $14.6M | Buy |
273,135
+38,944
| +17% | +$2.09M | ﹤0.01% | 1848 |
|
|
2024
Q3 | $10.6M | Buy |
234,191
+156,675
| +202% | +$7.12M | ﹤0.01% | 1996 |
|
|
2024
Q2 | $3.25M | Buy |
77,516
+28,258
| +57% | +$1.18M | ﹤0.01% | 2535 |
|
|
2024
Q1 | $1.85M | Buy |
49,258
+3,117
| +7% | +$117K | ﹤0.01% | 2615 |
|
|
2023
Q4 | $495K | Sell |
46,141
-2,609
| -5% | -$28K | ﹤0.01% | 3075 |
|
|
2023
Q3 | $491K | Buy |
48,750
+2,629
| +6% | +$26.5K | ﹤0.01% | 3042 |
|
|
2023
Q2 | $547K | Buy |
46,121
+729
| +2% | +$8.65K | ﹤0.01% | 3005 |
|
|
2023
Q1 | $549K | Sell |
45,392
-2,298
| -5% | -$27.8K | ﹤0.01% | 2921 |
|
|
2022
Q4 | $628K | Buy |
47,690
+1,127
| +2% | +$14.8K | ﹤0.01% | 2920 |
|
|
2022
Q3 | $631K | Buy |
46,563
+4,053
| +10% | +$54.9K | ﹤0.01% | 2934 |
|
|
2022
Q2 | $520K | Sell |
42,510
-1,890
| -4% | -$23.1K | ﹤0.01% | 3062 |
|
|
2022
Q1 | $637K | Buy |
44,400
+10,454
| +31% | +$150K | ﹤0.01% | 3025 |
|
|
2021
Q4 | $670K | Buy |
33,946
+1,370
| +4% | +$27K | ﹤0.01% | 3055 |
|
|
2021
Q3 | $705K | Buy |
+32,576
| New | +$705K | ﹤0.01% | 3020 |
|